|
|
Article: Compugen Reports Third Quarter 2009 Financial Results.(Financial report)
- Article from:
- Biotech Week
- Article date:
- November 11, 2009
CopyrightCOPYRIGHT 2009 NewsRX. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Compugen Ltd. (NASDAQ:CGEN) reported financial results for the third quarter ended September 30, 2009 (see also Compugen Ltd.).
Martin Gerstel, Compugen's co-CEO stated, "The industry interest and collaboration opportunities that we are now seeing for our company exist solely due to the broadly applicable drug and biomarker discovery capability that has been created at Compugen during the past decade. As we increase our focus on these commercialization opportunities, we will also continue to widen and deepen our leadership position in predictive discovery, which we are confident, will become increasingly important in drug and diagnostic research industry-wide. A ...
Related newspaper, magazine, and journal articles:
|
|
Article: Compugen Ltd. Reports Fourth Quarter and Year-End 2008 ...
Business Wire;
February 11, 2009 ;
700+ words
... ... broader collaborations." Compugen's financial results continue ... As of December 31, 2008, Compugen had $7.2 million in cash ... value of the 2.2 million Evogene shares (TASE:EVGN.TA) held ... Call and Webcast Information Compugen will hold a conference call ...
|
|